Cargando…

IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma

BACKGROUND: High-grade osteosarcoma is an aggressive tumor most often developing in the long bones of adolescents, with a second peak in the 5th decade of life. Better knowledge on cellular signaling in this tumor may identify new possibilities for targeted treatment. METHODS: We performed gene set...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuijjer, Marieke L, Peterse, Elisabeth FP, van den Akker, Brendy EWM, Briaire-de Bruijn, Inge H, Serra, Massimo, Meza-Zepeda, Leonardo A, Myklebost, Ola, Hassan, A Bassim, Hogendoorn, Pancras CW, Cleton-Jansen, Anne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672007/ https://www.ncbi.nlm.nih.gov/pubmed/23688189 http://dx.doi.org/10.1186/1471-2407-13-245

Ejemplares similares

Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
por: Kuijjer, Marieke L, et al.
Publicado: (2014)

mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
por: Kuijjer, Marieke L, et al.
Publicado: (2011)

Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
por: Namløs, Heidi M., et al.
Publicado: (2012)

Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
por: Baranski, Zuzanna, et al.
Publicado: (2015)

Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
por: Kresse, Stine H., et al.
Publicado: (2012)

Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression
por: Franceschini, Natasja, et al.
Publicado: (2021)

MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
por: Baranski, Zuzanna, et al.
Publicado: (2015)

Osteosarcoma Models: From Cell Lines to Zebrafish
por: Mohseny, Alexander B., et al.
Publicado: (2012)

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
por: Willems, Stefan M, et al.
Publicado: (2010)

No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone
por: Peterse, Elisabeth F. P., et al.
Publicado: (2016)

In vitro studies of osteosarcoma: A researcher's perspective of quantity and quality
por: Peterse, Elisabeth F.P., et al.
Publicado: (2017)

Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture
por: Buddingh, Emilie P, et al.
Publicado: (2015)

MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma
por: Sarver, Aaron L, et al.
Publicado: (2013)

Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors: A Common Genomic Abnormality in Vascular Malformation/Hemangioma and Simple Bone Cyst
por: Ong, Sheena L.M., et al.
Publicado: (2021)

BCRP expression in schwannoma, plexiform neurofibroma and MPNST
por: de Vries, Maurits, et al.
Publicado: (2017)

NTRK fusions are extremely rare in bone tumours
por: Lam, Suk Wai, et al.
Publicado: (2021)

Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening
por: Grad, Iwona, et al.
Publicado: (2021)

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
por: Cleton-Jansen, A-M, et al.
Publicado: (2009)

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
por: Cleton-Jansen, A-M, et al.
Publicado: (2009)

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
por: Meijer, Danielle, et al.
Publicado: (2011)

Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma
por: Palubeckaitė, Ieva, et al.
Publicado: (2020)

Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas
por: van IJzendoorn, David G. P., et al.
Publicado: (2019)

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019)

Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
por: Barøy, Tale, et al.
Publicado: (2014)

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
por: van Maldegem, Annemiek M, et al.
Publicado: (2012)

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
por: Barøy, Tale, et al.
Publicado: (2016)

Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix
por: Willems, Stefan M, et al.
Publicado: (2009)

Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours
por: Kresse, Stine H, et al.
Publicado: (2010)

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
por: Schrage, Yvonne M, et al.
Publicado: (2009)

Mesenchymal stem cell transformation and sarcoma genesis
por: Xiao, Wei, et al.
Publicado: (2013)

CORR Insights(®): Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-β as Involved in the Pathogenesis of Osteosarcoma
por: Peterse, Elisabeth F. P., et al.
Publicado: (2015)

Increased dynamin expression precedes proteinuria in glomerular disease
por: Khalil, Ramzi, et al.
Publicado: (2018)

Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas
por: de Vries, Maurits, et al.
Publicado: (2012)

Expression of the immune regulation antigen CD70 in osteosarcoma
por: Pahl, Jens HW, et al.
Publicado: (2015)

Histological response to radiotherapy is an early event in myxoid liposarcoma
por: Lam, Suk Wai, et al.
Publicado: (2023)

A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival
por: de Jong, Yvonne, et al.
Publicado: (2019)

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
por: Li, Heming, et al.
Publicado: (2017)

M-CGH: Analysing microarray-based CGH experiments
por: Wang, Junbai, et al.
Publicado: (2004)

The clinical use of biomarkers as prognostic factors in Ewing sarcoma
por: van Maldegem, Annmeik M, et al.
Publicado: (2012)

Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors
por: Hoekstra, Attje S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cf99v05l3mku6ooe7tvqh46qd9